Pipeline overview
Largest psilocybin studies ever completed
COMPASS clinical trial programmes in treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa
Countries where COMP360 psilocybin studies are or have been conducted (COMPASS-sponsored clinical trials and investigator-initiated studies)
Investigator-initiated studies in progress/completed, in 9 areas of unmet need
Participants in completed COMPASS-sponsored clinical studies
Preclinical studies completed in COMP360 psilocybin
Integrated AI platform supporting therapists and patients
Pipeline overview
COMPASS development programmes
COMPASS-owned and sponsored
Programme
COMP360 for TRD
Phase 3
COMP360 for PTSD
Phase 2
COMP360 for anorexia nervosa
Phase 2
Prodrug programme
Preclinical
Discovery Center
Preclinical
Investigator-initiated studies
Signal-generating exploratory studies looking at indications in areas of unmet need with COMP360
- Studies may provide signals that we can explore further and bring into our development pipeline
Indication
Institution
CMPS financed
Status
Indication: MDD
Institution: Imperial College London
Status: Complete (published)
Indication: MDD in cancer patients
Institution: Aquilino Cancer Center
Status: Complete (published)
Indication: MDD
Institution: University of Zurich
Status: Complete
Indication: Chronic cluster headache
Institution: University of Copenhagen
Status: Complete
Indication: Body dysmorphic disorder
Institution: Columbia University
Status: Complete
Indication: Severe TRD
Institution: Sheppard Pratt
Status: Complete
Indication: Bipolar disorder II
Institution: Sheppard Pratt
Status: Complete
Indication: Anorexia nervosa
Institution: UC San Diego
Status: Complete
Indication: Suicidal ideation
Institution: Sheppard Pratt
Status: Ongoing
Indication: Autism
Institution: King's College London
Status: Ongoing
Indication: TRD
Institution: Stanford
Status: Ongoing
Indication: Rumination
Institution: Mass General
Status: Ongoing
Note: TRD = treatment-resistant depression, PTSD = post-traumatic stress disorder, MDD = major depressive disorder. We do not sponsor investigator-initiated studies, some of which use their own protocols and study design. We encourage open publication of all associated findings from any study or trial using COMP360.